CN1195055C - Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues - Google Patents
Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues Download PDFInfo
- Publication number
- CN1195055C CN1195055C CNB011311908A CN01131190A CN1195055C CN 1195055 C CN1195055 C CN 1195055C CN B011311908 A CNB011311908 A CN B011311908A CN 01131190 A CN01131190 A CN 01131190A CN 1195055 C CN1195055 C CN 1195055C
- Authority
- CN
- China
- Prior art keywords
- cell
- placenta
- stem cell
- cells
- hemopoietic stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 210000005059 placental tissue Anatomy 0.000 title claims description 65
- 210000003958 hematopoietic stem cell Anatomy 0.000 title description 26
- 210000004027 cell Anatomy 0.000 claims abstract description 206
- 210000003995 blood forming stem cell Anatomy 0.000 claims abstract description 81
- 210000004700 fetal blood Anatomy 0.000 claims abstract description 72
- 210000002826 placenta Anatomy 0.000 claims abstract description 69
- 210000000130 stem cell Anatomy 0.000 claims abstract description 60
- 238000001514 detection method Methods 0.000 claims abstract description 30
- 201000010099 disease Diseases 0.000 claims abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 230000003394 haemopoietic effect Effects 0.000 claims description 23
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 15
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 210000001519 tissue Anatomy 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 14
- 210000005087 mononuclear cell Anatomy 0.000 claims description 13
- 235000015097 nutrients Nutrition 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 12
- 230000002631 hypothermal effect Effects 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 229920002307 Dextran Polymers 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 9
- 210000004698 lymphocyte Anatomy 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 8
- 210000003714 granulocyte Anatomy 0.000 claims description 7
- 239000002504 physiological saline solution Substances 0.000 claims description 7
- 210000002381 plasma Anatomy 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 210000000265 leukocyte Anatomy 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 239000012930 cell culture fluid Substances 0.000 claims description 5
- 210000003954 umbilical cord Anatomy 0.000 claims description 5
- 208000030507 AIDS Diseases 0.000 claims description 4
- 238000011109 contamination Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 206010018833 Haematocoele Diseases 0.000 claims description 3
- 208000005873 Hematocele Diseases 0.000 claims description 3
- 208000007536 Thrombosis Diseases 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 230000000890 antigenic effect Effects 0.000 claims description 3
- 230000006907 apoptotic process Effects 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 238000004043 dyeing Methods 0.000 claims description 3
- 238000000684 flow cytometry Methods 0.000 claims description 3
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 claims description 3
- 230000002949 hemolytic effect Effects 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 210000005152 placental membrane Anatomy 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 239000003206 sterilizing agent Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims 7
- 239000002609 medium Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 239000011324 bead Substances 0.000 abstract description 11
- 238000002054 transplantation Methods 0.000 abstract description 9
- 230000007774 longterm Effects 0.000 abstract description 8
- 230000010261 cell growth Effects 0.000 abstract description 5
- 238000007710 freezing Methods 0.000 abstract description 5
- 230000008014 freezing Effects 0.000 abstract description 5
- 230000004083 survival effect Effects 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 4
- 238000004113 cell culture Methods 0.000 abstract description 2
- 238000011161 development Methods 0.000 abstract description 2
- 230000018109 developmental process Effects 0.000 abstract description 2
- 238000001976 enzyme digestion Methods 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 230000006978 adaptation Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 238000010297 mechanical methods and process Methods 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 21
- 230000000740 bleeding effect Effects 0.000 description 21
- 210000001113 umbilicus Anatomy 0.000 description 21
- 230000012010 growth Effects 0.000 description 15
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 13
- 230000003169 placental effect Effects 0.000 description 13
- 238000000746 purification Methods 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 10
- 210000000601 blood cell Anatomy 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 8
- 230000037396 body weight Effects 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 230000003321 amplification Effects 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 238000012637 gene transfection Methods 0.000 description 5
- 230000008676 import Effects 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229930003756 Vitamin B7 Natural products 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000011132 hemopoiesis Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000011735 vitamin B7 Substances 0.000 description 4
- 235000011912 vitamin B7 Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000024908 graft versus host disease Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 102100021908 3-mercaptopyruvate sulfurtransferase Human genes 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 101000753843 Homo sapiens 3-mercaptopyruvate sulfurtransferase Proteins 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 210000000630 fibrocyte Anatomy 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- FSPQCTGGIANIJZ-UHFFFAOYSA-N 2-[[(3,4-dimethoxyphenyl)-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NC1=C(C(N)=O)C(CCCC2)=C2S1 FSPQCTGGIANIJZ-UHFFFAOYSA-N 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000013925 CD34 antigen Human genes 0.000 description 1
- 108050003733 CD34 antigen Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000035185 Hemolytic Congenital Anemia Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 206010060893 Hereditary haemolytic anaemia Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
- 101710151245 Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000002583 cell-derived microparticle Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000001516 congenital hemolytic anemia Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 208000024987 familial hemolytic anemia Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Images
Abstract
Description
Colony begins formation time | The colony size | The granulocyte colony form | Repeatedly colony is cultivated | Attached cell | Attached cell is gone down to posterity | |
Medullary cell | 5 days | Colony includes the about 50-200 of cell | Cell is little, circle, and growth disperses | Only can generate colony one time | The small amount of fibers like cell | Difficulty |
The placenta tissue cell | 9 days | Colony includes cell greater than 1,000, and form superpose cell | Cell is big, circle, periphery is irregular, growth is concentrated, and is overlapped | Can generate colony four times | A large amount of or sheet, fibroblast-like cell cover with culture dish | 10-20 generation |
Cord blood cells | 7 days | Colony includes the about 200-1,000 of cell | Cell is big, circle, and it is comparatively concentrated to grow | Can generate the secondary colony | The more fibrocyte of shape looses | 2-4 generation |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011311908A CN1195055C (en) | 2001-09-06 | 2001-09-06 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011311908A CN1195055C (en) | 2001-09-06 | 2001-09-06 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1407088A CN1407088A (en) | 2003-04-02 |
CN1195055C true CN1195055C (en) | 2005-03-30 |
Family
ID=4670427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011311908A Expired - Fee Related CN1195055C (en) | 2001-09-06 | 2001-09-06 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1195055C (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
WO2005001079A2 (en) | 2003-06-27 | 2005-01-06 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
JP5340599B2 (en) | 2004-12-23 | 2013-11-13 | エシコン・インコーポレイテッド | Umbilical tissue-derived postpartum cells and methods for producing and using the same |
PE20070771A1 (en) | 2005-10-13 | 2007-08-11 | Anthrogenesis Corp | IMMUNOMODULATION THROUGH THE USE OF PLACENTA STEM CELLS |
EP2471904B1 (en) * | 2005-12-29 | 2018-10-24 | Celularity, Inc. | Placental stem cell populations |
NZ597779A (en) | 2007-02-12 | 2013-07-26 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
CN101688177A (en) | 2007-02-12 | 2010-03-31 | 人类起源公司 | Liver cell and chondrocyte from adherent placental stem cells; And CD34 +, CD45 -The cell mass of placenta stem-cell enrichment |
SI2203176T1 (en) | 2007-09-28 | 2015-04-30 | Anthrogenesis Corporation | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
AU2008308531B2 (en) | 2007-10-05 | 2014-04-24 | Ethicon, Incorporated | Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
US8828376B2 (en) | 2008-08-20 | 2014-09-09 | Anthrogenesis Corporation | Treatment of stroke using isolated placental cells |
NZ591292A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
US8728805B2 (en) | 2008-08-22 | 2014-05-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
CN101889079B (en) * | 2008-10-17 | 2012-08-08 | 宁夏医科大学附属医院 | A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc |
RU2015130665A (en) | 2008-11-19 | 2018-12-24 | Антродженезис Корпорейшн | AMNIOTIC ADHESIVE CELLS |
CN107028983A (en) | 2008-12-19 | 2017-08-11 | 德普伊新特斯产品有限责任公司 | The treatment of PUD D and illness |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
US8722034B2 (en) | 2009-03-26 | 2014-05-13 | Depuy Synthes Products Llc | hUTC as therapy for Alzheimer's disease |
WO2011094181A1 (en) | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
PT2556145T (en) | 2010-04-07 | 2016-10-25 | Anthrogenesis Corp | Angiogenesis using placental stem cells |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
JP5996533B2 (en) | 2010-07-13 | 2016-09-21 | アントフロゲネシス コーポレーション | How to generate natural killer cells |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
CN102757935A (en) * | 2011-04-29 | 2012-10-31 | 北京汉氏联合生物技术有限公司 | Method for extracting hematopoietic stem cell from placental chorionic tissue and construction method of hematopoietic stem cell |
AU2012262273B2 (en) | 2011-06-01 | 2017-09-14 | Celularity Inc. | Treatment of pain using placental stem cells |
CN102618438A (en) * | 2012-04-11 | 2012-08-01 | 章毅 | System for detecting and screening umbilical cord blood stem cells |
CN102660499B (en) * | 2012-05-23 | 2014-02-19 | 郑州赛英科干细胞技术有限公司 | Placental hematopoietic stem cell and preparation method thereof and placental hematopoietic stem cell injection |
EP2953635A4 (en) | 2013-02-05 | 2016-10-26 | Anthrogenesis Corp | Natural killer cells from placenta |
CN103320382A (en) * | 2013-02-08 | 2013-09-25 | 周胜利 | Method for extracting and purifying multi-source stem cells from placenta and umbilical cord |
KR20160048029A (en) | 2013-03-15 | 2016-05-03 | 마르쿠스 카레 토를레이프 라르손 | Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells |
CN103743906B (en) * | 2013-07-24 | 2015-05-20 | 北京大学人民医院 | A kit, a system and a method for determining patient marrow microenvironment after hematopoietic stem cell transplantation |
US11542473B2 (en) | 2016-10-21 | 2023-01-03 | Amniotics Ab | Methods and compositions for generating hematopoietic cells |
CN107714726A (en) * | 2017-10-16 | 2018-02-23 | 中国科学院广州生物医药与健康研究院 | A kind of method for remolding bone marrow microenvironment |
CN109294979A (en) * | 2018-11-01 | 2019-02-01 | 中晶生物技术股份有限公司 | A kind of method and application efficiently separating umbilical cord and placenta mesenchymal stem cell |
EP4234019A3 (en) | 2019-10-18 | 2023-09-13 | Amniotics AB | Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof |
CN110903952B (en) * | 2019-11-06 | 2023-05-26 | 天晴干细胞股份有限公司 | Method for separating and purifying placenta blood and resuscitating by using protective liquid and placenta extruder |
CN111685103A (en) * | 2020-06-18 | 2020-09-22 | 深圳市北科生物科技有限公司 | Cryopreservation method for umbilical cord blood hematopoietic stem cells |
-
2001
- 2001-09-06 CN CNB011311908A patent/CN1195055C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1407088A (en) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1195055C (en) | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues | |
US7060494B2 (en) | Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof | |
US7897388B2 (en) | Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation for therapeutic purposes | |
CN100441682C (en) | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells | |
US10967110B2 (en) | System and methods for preparation of adipose-derived stem cells | |
CN105985985A (en) | Preparation method of allogenic mesenchymal stem cells by CRISPR (clustered regularly interspaced short palindromic repeats) technique editing and IGF (insulin-like growth factor) optimization and application of allogenic mesenchymal stem cells in treating myocardial infarction | |
CN103263440A (en) | Method for extracting and preparing homology mesenchymal stem cell injection from placenta and umbilical cord | |
CN103320382A (en) | Method for extracting and purifying multi-source stem cells from placenta and umbilical cord | |
CN110157666A (en) | Umbilical cord mesenchymal stem cells MSCs and its cultural method and application | |
CN102517251A (en) | Mesenchymal stem cells, as well as preparation method and application thereof | |
CN101591644A (en) | The preparation of umbilical cord-mesenchymal stem cells (UC-MSCs) used in clinical therapy and storage | |
CN104357396A (en) | Method for extracting early hematopoietic progenitor stem cells and application thereof | |
WO2019161590A1 (en) | Mesenchymal stem cell suspension and preparation method therefor and application thereof | |
CN114134114B (en) | Method for amplifying natural killer cells from placenta tissue | |
CN104152405B (en) | The method of separation and Extraction hematopoietic stem cell from Placenta Hominis | |
CN102191229A (en) | Method for rapidly and effectively acquiring umbilical cord mesenchymal stem cell (MSC) | |
CN101161249B (en) | Method for extracting original mesenchyma and hematopoiesis trunks/ancestral cell from caesarean birth placenta | |
CN1778905A (en) | Separating culture and use for fatty mesenchymal dry cell | |
CN108728408B (en) | Canine fetal membrane mesenchymal stem cell, preparation method and culture medium used by same | |
CN103756965B (en) | A kind of method of lavation hemopoietic stem cell from placenta | |
CN108642013A (en) | From being detached in Cord blood after CD34 candidate stem cells expand culture, induction prepares Dendritic Cells method to one kind on a large scale | |
CN108841787A (en) | The influence for the excretion body that EPO discharges mescenchymal stem cell | |
CN102065871A (en) | A novel composition of stem cells transplantation tolerance | |
CN101412987A (en) | Method for amplifying in vitro mesenchymal stem cells | |
CN1932010A (en) | Process of separating endothelial ancestral cell from human fat tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Hu Yulan Document name: Notification of the application for patent for invention to go through the substantive examination procedure |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: HU YULAN Effective date: 20131202 Owner name: CELL PARK (JIANGSU) STEM CELLS BIOLOGICAL ENGINEER Free format text: FORMER OWNER: ZHOU SHENGLI Effective date: 20131202 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100085 HAIDIAN, BEIJING TO: 224200 YANCHENG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131202 Address after: 224200 Jiangsu City, Dongtai Province Coastal Economic Zone, Metro North Road, No. 6 Patentee after: Sail Parke (Jiangsu) stem cell biology engineering Co. Ltd. Address before: 100085 No. 2, unit 4, building 601, Qing Lin Yuan, Beijing, Haidian District Patentee before: Zhou Shengli Patentee before: Hu Yulan |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170418 Address after: 200335 room 5F-704, Hami Road, Shanghai, Changning District, 1955 Patentee after: Shanghai thick East Biotechnology Co., Ltd. Address before: 224200 Jiangsu City, Dongtai Province Coastal Economic Zone, Metro North Road, No. 6 Patentee before: Sail Parke (Jiangsu) stem cell biology engineering Co. Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050330 Termination date: 20200906 |
|
CF01 | Termination of patent right due to non-payment of annual fee |